| Generic N | Indication | |
|---|---|---|
| AIDS vaccine-2,GlaxoSmithKline | Infection, HIV/AIDS | |
| Detox | Vaccine | |
| HPV vacci | Cancer, cervical Infection, human papilloma virus prophylaxis | |
| Hepatitis- | Infection, hepatitis B virus prophy-laxis | |
| Herpes simplex vaccine, GSK | Infection, herpes simplex virus prophylaxis Infection, herpes simplex vaccine | |
| RC-552 | Ischaemia, general Reperfusion injury | |
| Malaria va | Infection, malaria prophylaxis | |
| Tuberculos | Infection, tuberculosis prophylaxis | |
| WT1 vacci | Cancer, leaukaemia | |
| Tuberculos | Infection, tuberculosis Infection, tuberculosis prophylaxis | |
| Table 1: Examples of compounds that are, and have been under development by GlaxoSmithKline, which contain the MPL adjuvant. | ||